<SEC-DOCUMENT>0000950170-25-052088-index.html : 20250408
<SEC-HEADER>0000950170-25-052088.hdr.sgml : 20250408
<ACCEPTANCE-DATETIME>20250408162504
ACCESSION NUMBER:		0000950170-25-052088
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250408
DATE AS OF CHANGE:		20250408
EFFECTIVENESS DATE:		20250408

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			REGENXBIO Inc.
		CENTRAL INDEX KEY:			0001590877
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				471851754
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37553
		FILM NUMBER:		25822293

	BUSINESS ADDRESS:	
		STREET 1:		9804 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		240-552-8181

	MAIL ADDRESS:	
		STREET 1:		9804 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	REGENXBIO, Inc.
		DATE OF NAME CHANGE:	20150116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ReGenX Biosciences, LLC
		DATE OF NAME CHANGE:	20131101
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>rgnx-ars-2024.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: rgnx-ars-2024.pdf

</DOCUMENT>
</SEC-DOCUMENT>